¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"insulin shock therapy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • conjoint therapy
    ÇÕµ¿¿ä¹ý
  • consolidation therapy
    °­È­¿ä¹ý
  • corrective therapy
    ±³Á¤¿ä¹ý
  • couples therapy
    ºÎºÎ¿ä¹ý
  • drug therapy
    ¾à¹°¿ä¹ý
  • diathermic therapy
    Åõ°ú¿­¿ä¹ý
  • directive group therapy
    Áö½ÃÁý´Ü¿ä¹ý
  • electroconvulsive therapy
    Àü±â°æ·Ã¿ä¹ý
  • endocrine therapy
    ³»ºÐºñ¿ä¹ý
  • estrogen replacement therapy
    ¿¡½ºÆ®·Î°Õ´ëÄ¡¿ä¹ý
  • fever therapy
    ¹ß¿­¿ä¹ý
  • gene therapy
    À¯ÀüÀÚ¿ä¹ý
  • gene transfer therapy
    À¯ÀüÀÚÀ̽Ŀä¹ý
  • hypothermia therapy
    Àúü¿Â¿ä¹ý
  • hormone replacement therapy
    È£¸£¸ó´ëġġ·á
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • microwave therapy apparatus
    ±ØÃÊ´ÜÆÄÄ¡·á±â
  • bacterial interference therapy
    ¼¼±Õ°£¼·¿ä¹ý
  • behavioral therapy
    Çൿ¿ä¹ý
  • biologic therapy
    »ý¹°ÇÐÀûÁ¦Á¦¿ä¹ý
  • boron-neutron capture therapy
    º¸·ÐÁß¼ºÀÚÆ÷ȹ¿ä¹ý
  • client-centered therapy
    ³»´ãÀÚÁ߽ɿä¹ý, ÀÇ·ÚÀÎÁ߽ɿä¹ý
  • cognitive therapy
    ÀÎÁö¿ä¹ý
  • cold therapy
    ÇÑ·©¿ä¹ý
  • combined modality therapy
    º´¿ë¿ä¹ý
  • compression therapy
    ¾Ð¹Ú¿ä¹ý
  • conformal dynamic therapy
    ÀÔüÁ¶Çüµ¿Àû¿ä¹ý
  • conformal radiation therapy
    ÀÔüÁ¶Çü¹æ»ç¼±¿ä¹ý
  • conjoint therapy
    ÇÕµ¿¿ä¹ý
  • consolidation therapy
    °­È­¿ä¹ý
  • corrective therapy
    ±³Á¤¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • heparin therapy monitoring
    ÇìÆÄ¸°¿ä¹ý<--Ä¡·á>°¨½Ã
  • hyperbaric oxygen therapy
    °í¾Ð»ê¼Ò¿ä¹ý
  • hyperbaric oxygenation therapy
    °í¾Ð»ê¼Ò¿ä¹ý(ÍÔäâß«áÈèþÛö)
  • immunization therapy
    ¸é¿ª¿ä¹ý(Øóæ¹èþÛö).
  • immunization therapy
    ¸é¿ª¿ä¹ý(¸é¿ª¿ä¹ý).
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý(¡­åäð¤èþÛö).
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý
  • implosive therapy
    ³»ÆÄ Ä¡·á
  • inhalation therapy =i. treatment
    ÈíÀÔ ¿ä¹ý.
  • intensification therapy
    Áõ°­¿ä¹ý.
  • intensity modulated radiation therapy
    °­µµº¯Á¶ ¹æ»ç¼±Ä¡·á
  • photodynamic therapy
    ±¤¼±¿ªÇпä¹ý
  • photodynamic therapy
    ±¤¿ªÇÐÄ¡·á
  • physical therapy
    ¹°¸®Ä¡·á,¹°¸®¿ä¹ý
  • physical therapy technician
    ¹°¸® ¿ä¹ý ±â»ç(ÚªìµèþÛöÐüÞÔ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • cardiogenic shock
    ½ÉÀμº ¼ï.
  • cardiogenic shock
    ½ÉÀμº¼ï (ãýì×àõ - )
  • cardiogenic shock
    ½ÉÀμº(ãýì×àõ)¼ï
  • cardiogenic shock
    ½ÉÀμº ¼ï(ãýì×àõ ¡­)
  • circulatory shock
    ¼øÈ¯¼º(âàü»àõ) ¼ï
  • circulatory shock
    ¼øÈ¯¼º ¼ï.
  • cold osmotic shock
    ÇÑ·©»ïÅõ¾Ð Ãæ°Ý
  • conditioning shock =c. stimulus
    Á¶°ÇÀÚ±Ø.
  • counter shock
    ¿ªÃæ°Ý, Ä«¿îÅͼï.
  • culture shock
    ¹®È­Ãæ°Ý(Ùþûùõú̪)
  • diastolic shock
    È®Àå±â¼ï.
  • direct current shock
    Á÷·ùÀü°Ý¼ï.
  • direct current shock
    Á÷·ùÀü±Ø¼ï.
  • drug shock
    ¾à¹°Ãæ°Ý(¡­õú̪).
  • dye shock
    »ö¼ÒÃæ°Ý.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
TSS Toxic Shock Syndrome
TSST-1 Toxic Shock Syndrome Toxin-1
  = Enterotoxin type F
CGS cardiogenic shock; catgut suture
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
DHF/DSS dengue hemorrhagic fever/ dengue shock syndrome
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
HSP72 Heat shock protein 72
HSP90 Heat shock protein 90
HSF Heat shock transcription factor
HSF-1 Heat shock transcription factor 1
hsp72 Heat-shock protein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • laser therapy
    ·¹ÀÌÀú Ä¡·á
    ÁÖ·Î ÃâÇ÷ÀÌ Àû¾î¾ß Çϰųª µ¿ÅëÀÌ ½ÉÇÑ È¯ÀÚÀÇ ¼ö¼úÀ̳ª »óóÀÇ À¶ÇÕ, Á¶Á÷ÀÇ ÆÄ±« µî¿¡ »ç¿ëµÈ´Ù.
  • light therapy
    ±¤¼± Ä¡·á
  • microwave therapy
    ±ØÃÊ´ÜÆÄ ¿ä¹ý
    ÆÄÀå 1 m ÀÌÇÏ, 1 mm ÀÌ»óÀÇ ÀüÀÚÆÄ¸¦ ÀÌ¿ëÇÏ´Â Àü±â¿ä¹ý. ¸¶ÀÌÅ©·Î¿þÀÌºê ¿ä¹ý , ¸¶ÀÌÅ©·ÎÆÄ ¿ä¹ýÀ̶ó°íµµ ÇÑ´Ù. º¸Åë ÀÇ·á¿ë¿¡´Â 12.5 cmÀÇ ÆÄÀåÀÌ Ã¤¿ëµÇ°í ÀÖ´Ù. ¸¶±×³×Æ®·ÐÀ̶ó´Â Áø°ø°ü¿¡¼­ ¹ßÁøµÇ¾î ¹Ý¿øÇü ¶Ç´Â °¢ÇüÀÇ Á¶»ç ÀåÄ¡·Î 5~10 cmÀÇ °Å¸®¿¡¼­ ȯºÎ¸¦ Á¶»çÇÑ´Ù. ÀÎü¿¡ Á¶»çÇÏ¿´À» ¶§ 3~4 cm¿¡¼­ ´ëºÎºÐ Èí¼öµÇ°í, ±× ¿¡³ÊÁö´Â ¿­·Î º¯ÇÑ´Ù. Áï, ½É´Þ¼ºÀº ÃÊ´ÜÆÄº¸´Ù ÀÛ°í Àû¿Ü¼±º¸´Ù´Â Å©´Ù. ±×·¸°Ô ±íÁö ¾ÊÀº Á¶Á÷¿¡ ´ëÇÑ ¿Â¿­¿ä¹ýÀ¸·Î ¾²À̸ç, ³ú, ´«, °íȯ µî°ú °°ÀÌ Ç÷ÇàÀÌ ÀûÀº ±â°ü¿¡¼­´Â °ú¿­µÉ À§ÇèÀÌ ÀÖÀ¸¹Ç·Î Á¶»çÇÒ ¶§ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù.
  • music therapy
    À½¾Ç ¿ä¹ý
  • non-reversible therapy
    ºñ°¡¿ªÀûÀÎ Ä¡·á
  • nonvital pulp therapy technique
    ½ÇȰ Ä¡¼ö Ä¡·á ¼ú½Ä
  • occlusal splint therapy
    ±³ÇÕ ÀåÄ¡ ¿ä¹ý
  • occlusal therapy
    ±³ÇÕ Ä¡·á
  • occupational therapy
    ÀÛ¾÷ ¿ä¹ý
    Ä¡·á ¸ñÀûÀ» À§ÇÑ ÀÛ¾÷ÀÇ Àû¿ë.
  • palliative therapy
    °í½ÄÀû Ä¡·á
  • prosthodontic therapy
    º¸Ã¶ Ä¡·á
  • radiation therapy
    ¹æ»ç¼± Ä¡·á
    °í¿¡³ÊÁö ¹æ»ç¼±À¸·Î ¾Ï ¼¼Æ÷¸¦ Á×À̰ųª ¼Õ»ó½ÃŰ´Â Ä¡·á¹ý. ¿ÜºÎ ¹æ»ç¼± Ä¡·á´Â °í¿¡³ÊÁö ¹æ»ç¼±À» ü¿Ü¿¡¼­ ¾Ï¿¡ Á¶ÁØÇÏ¿© ÂÉÀÌ´Â °ÍÀÌ´Ù. ³»ºÎ ¹æ»ç¼± Ä¡·á´Â ¹æ»ç¼º ¹°ÁúÀ» ü³» ¾Ï °¡±î¿î °÷¿¡ ³Ö¾î Ä¡·áÇÏ´Â °ÍÀÌ´Ù.
  • radioactive iodine therapy
    ¹æ»ç¼± Ȱ¼º ¿ä¿Àµå Ä¡·á
  • reality therapy
    Çö½Ç Ä¡·á
  • rehabilitative therapy
    ÀçÆÈ ¿ä¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
chronic shock The state of peripheral circulatory insufficiency developing in elderly patients with a debilitating disease, e.g., carcinoma; a subnormal blood volume makes the patient susceptible to haemorrhagic shock as a result of even a moderate blood loss such as may occur during an operation.
(05 Mar 2000)
wet shock A severe condition that occurs when the level of blood glucose (sugar) drops quickly. The signs are shaking, sweating, dizziness, double vision, convulsions, and collapse. Insulin shock may occur when an insulin reaction is not treated quickly enough.
See: hypoglycaemia.
(09 Oct 1997)
cultural shock A form of stress associated with the beginning of an individual's assimilation into a new culture vastly different from that in which he or she was raised.
(05 Mar 2000)
haemorrhagic shock Hypovolaemic shock resulting from acute haemorrhage, characterised by hypotension, tachycardia, pale, cold, and clammy skin, and oliguria.
(05 Mar 2000)
primary shock Shock mainly nervous in nature, from pain, anxiety, etc., which ensues almost immediately upon the receipt of a severe injury.
(05 Mar 2000)
heat-shock factor <cell biology, protein> A class of molecular chaperones found in both prokaryotes and in several compartments of eukaryotic cells. There is evidence that these proteins can interact with polypeptides during a variety of assembly processes in such a way as to prevent the formation of nonfunctional structures.
(12 Dec 1998)
Previous: heat-shock factor, heat-shock gene, heat-shock protein, heat-shock protein 27 kinaseNext: heat-shock proteins 90, heat-shock responseheat-shock factor -->heat-shock proteins 90
<cell biology, protein> A class of molecular chaperones whose members act in the mechanism of signal transduction by steroid receptors.
(12 Dec 1998)
heat-shock gene <molecular biology> A set of genes present in most animals which are transcribed suddenly, quickly, and with coordination when the animal is exposed to certain types of stress such as a sudden temperature increase.
(09 Oct 1997)
heat-shock protein <cell biology, molecular biology, protein> Families of proteins conserved through prokaryotic and eukaryotic cells and bacteria in response to hyperthermia and other environmental stresses, although some are constitutively expressed. They increase thermal tolerance and perform functions essential to cell survival under these conditions.
Some serve to stabilise proteins in abnormal configurations, play a role in folding and unfolding of proteins and the assembly of oligomeric complexes and may act as chaperonins. Hsp90 complexes with inactive steroid hormone receptor and is displaced upon ligand binding.
Four major sub classes are recognised: hsp90, hsp70, hsp60 and small hsps. Hsps have been suggested to act as major immunogens in many infections.
Acronym: HSP
(12 Dec 1998)
heat-shock protein 27 kinase <enzyme> Phosphorylates hsp 26 on serine residues when stimulated by tumour necrosis factor or interleukin 1
Registry number: EC 2.7.1.-
Synonym: hsp 27 kinase, heat-shock protein 27 kinase, hsp27 kinase
(26 Jun 1999)
heat-shock proteins 70 <cell biology, protein> A class of molecular chaperones found in both prokaryotes and in several compartments of eukaryotic cells. There is evidence that these proteins can interact with polypeptides during a variety of assembly processes in such a way as to prevent the formation of nonfunctional structures.
(12 Dec 1998)
heat-shock proteins 90 <cell biology, protein> A class of molecular chaperones whose members act in the mechanism of signal transduction by steroid receptors.
(12 Dec 1998)
heat-shock response <cell biology> A constellation of responses that occur when an organism is exposed to excessive heat and other environmental stresses. Responses include synthesis of some proteins, repression of other proteins, and expression of new proteins.
(12 Dec 1998)
heat-shock response element <cell biology, protein> The nucleotide sequence, CNNGAANNTCCNG, which is in the promoter region of the heat-shock genes. When the animal is exposed to certain types of stress such as a sudden rise in temperature, the first thing that happens to activate these genes is the binding of the HSE by a transcriptional enhancer protein.
(09 Oct 1997)
protein shock The systemic reaction following the parenteral administration of a protein.
(05 Mar 2000)
pseudoanaphylactic shock A reaction that is similar to anaphylactic shock, but which does not require the incubation period characteristic of induced sensitivity (anaphylaxis); it is unrelated to antigen-antibody reactions.
Synonym: anaphylactoid crisis, pseudoanaphylactic shock.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á